JPRN-UMIN000003974已完成未知
Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial (KABUTO-AF Trial) - Kyoto Aldosterone Blocker Upstream Therapy on Atrial Fibrillation Trial (KABUTO-AF Trial)
KPUM KABUTO-AF study investigators0 个研究点目标入组 100 人开始时间: 2010年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Previous administration of eplerenone Low EF<40% Symptomatic heart failure (NYHA>II) Enlarged LAD>55mm Valvular disease requiring surgical operation chronic Af ACS<30 days Cardiogenic shock Contraindication for Eplerenone Intolerance to Eplerenone Scheduled Cardiac surgery within 1year Scheduled Catheter ablation within 1 year Symptomatic arterial hypotension Secondary hypertension ICD pacemaker program change for af suppression options pregnancy Chronic inflammatory disease Malignancy Severe infection Life expectancy<1years eGFR<40 Dialysis Severe Liver dysfunction Drug addiction Alcohol abuse Inability to give informed consent
研究者
相似试验
进行中（未招募）
1 期
Optimizing medical therapy in patients with heart failureHeart failureEUCTR2020-005176-35-SESahlgrenska University Hospital230
进行中（未招募）
1 期
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosilicate in Heart Failure (OPRA-HF)High-risk hyperkalemia, Heart failure, Suboptimal heart failure treatmentMedDRA version: 20.0Level: HLTClassification code: 10019283Term: Heart failure signs and symptoms Class: 10007541CTIS2024-511502-24-02Vaestra Goetalandsregionen1
进行中（未招募）
1 期
ALdosterone antagonist Chronic HEModialysis Interventional Survival Trialend-stage renal failure (ESRF)cardiovascular complicationMedDRA version: 20.0Level: PTClassification code 10007649Term: Cardiovascular disorderSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10050441Term: Chronic renal insufficiencySystem Organ Class: 100000004857EUCTR2012-002856-18-BECHRU de Brest825
进行中（未招募）
不适用
ALdosterone antagonist Chronic HEModialysis Interventional Survival TrialEUCTR2012-002856-18-FRCHRU de Brest
进行中（未招募）
不适用
Aldosterone receptor blockade in patients with chronic kidney disease.Influence on arterial stiffness and kidney function. - ALBLOCK-2Chronic kidney disease, stages 3 and 4.MedDRA version: 9.1Level: LLTClassification code 10064848Term: Chronic kidney diseaseEUCTR2009-012445-35-DKHerlev Hospital80